Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Amortizatization of Intangibles (2016 - 2025)

Corcept Therapeutics' Amortizatization of Intangibles history spans 9 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 2444.69% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $5.1 million, up 843.25%, while the annual FY2025 figure was $5.1 million, 843.25% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $4.6 million at Corcept Therapeutics, up from $188000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $7.9 million in Q4 2023 and bottomed at $57000.0 in Q3 2023.
  • The 5-year median for Amortizatization of Intangibles is $499000.0 (2021), against an average of $947700.0.
  • The largest annual shift saw Amortizatization of Intangibles tumbled 97.72% in 2024 before it surged 2444.69% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $508000.0 in 2021, then increased by 11.02% to $564000.0 in 2022, then soared by 1294.68% to $7.9 million in 2023, then crashed by 97.72% to $179000.0 in 2024, then soared by 2444.69% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Amortizatization of Intangibles are $4.6 million (Q4 2025), $188000.0 (Q3 2025), and $183000.0 (Q2 2025).